Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia
Current Urology Reports · 2025-12 · 26 (1)
DOI: 10.1007/s11934-024-01235-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Urology Reports, online erschienen am 07.10.2024. Verfasst von John Lama und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Weill Cornell Medicine, New York City, NY, USA. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Stents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
PURPOSE OF REVIEW: The prevalence of benign prostatic hyperplasia (BPH) is rising, however, current treatment options present severe complications and limit patient's quality of life. Accordingly, advancements in prostatic catheter and stent designs for use in treating lower urinary tract symptoms (LUTS) in BPH patients have largely expanded in the past five years and we aim to provide an exhaustive summary of recent outcomes. RECENT FINDINGS: The dual dilation and paxlitaxel eluting Optilume BPH Catheter System enhances promise in catheter-based treatments, providing the longest sustained increase in max urinary flow rate and decrease in post-void residual volume compared to alternative MISTs. Additionally, use of iTiND, along with recent advancements in temporary (EXIME, Prodeon Urocross) and permanent (Zenflow Spring, Butterfly, and ClearRing) stent designs, have demonstrated rapid, lasting, and low-cost LUTS relief with sustained sexual function. Minimally invasive solutions that offer in-office treatment, rapid symptom relief, shorter recovery times, and preservation of sexual function hold great promise in improving outcomes in managing BPH patients with LUTS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Weill Cornell Medicine, New York City, NY, USA.
- Department of Urology, Northwell Health, Manhasset, NY, USA.
- Department of Urology, University of Montreal, Montreal, Canada.
- Division of Urology, University of Toronto, Toronto, Canada.
- BPHCanada Prostate Surgery Institute, Montreal, QC, Canada.
- Department of Urology, Northwell Health, Manhasset, NY, USA. bchughtai@northwell.edu.
Zitieren
APA
Lama, J., Winograd, J., Codelia-Anjum, A., Bhojani, N., Elterman, D., Zorn, K. C., & Chughtai, B. (2025). Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia. Current Urology Reports, 26(1). https://doi.org/10.1007/s11934-024-01235-3
Vancouver
Lama J, Winograd J, Codelia-Anjum A, Bhojani N, Elterman D, Zorn KC, et al. Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia. Current Urology Reports. 2025;26(1). doi:10.1007/s11934-024-01235-3
BibTeX
@article{Lama2025,
author = {Lama, John and Winograd, Joshua and Codelia-Anjum, Alia and Bhojani, Naeem and Elterman, Dean and Zorn, Kevin C and Chughtai, Bilal},
title = {Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia},
journal = {Current Urology Reports},
year = {2025},
volume = {26},
number = {1},
doi = {10.1007/s11934-024-01235-3}
}
EUVIMED